Overview
Thymosin Beta-4 is a naturally occurring peptide composed of 43 amino acids, primarily produced in the thymus gland. It acts as a major actin-sequestering molecule in eukaryotic cells, playing a fundamental role in cell proliferation, migration, and differentiation. Because it can be found in high concentrations in blood platelets and at the site of injuries, it is widely regarded as a primary coordinator of the body's natural tissue repair response.
In a research context, this peptide is highly valued for its ability to promote angiogenesis—the formation of new blood vessels—and its potent anti-inflammatory effects. Beyond simple wound healing, it has shown potential in protecting the heart, liver, and brain from oxidative stress and fibrotic scarring. It is often utilized by athletes looking to decrease recovery time or by those seeking to treat chronic inflammatory conditions or degenerative tissue damage.
Mechanism of action
Upregulates vascular endothelial growth factor (VEGF) to promote angiogenesis and sequesters actin monomers to facilitate cell migration and tissue regeneration.
Reported benefits
- ▸Accelerates recovery from muscle, tendon, and ligament injuries
- ▸Reduces systemic and localized inflammation by inhibiting cytokines
- ▸Supports cardiovascular health and cardiac tissue repair post-MI
- ▸Promotes corneal healing and relief from dry eye symptoms sprays
- ▸Stimulates hair follicle growth and dermal repair
- ▸Enhances flexibility and reduces the formation of scar tissue
Reported side effects
- ·Redness/irritation at injection site
- ·Lethargy or tiredness
- ·Headaches
- ·Potential risk of promoting existing tumor metastasis due to angiogenic properties
Often stacked with
BPC-157